Nakhleh, A.; Othman, A.; Masri, A.; Zloczower, M.; Zolotov, S.; Shehadeh, N.
Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study. Biomedicines 2023, 11, 2689.
https://doi.org/10.3390/biomedicines11102689
AMA Style
Nakhleh A, Othman A, Masri A, Zloczower M, Zolotov S, Shehadeh N.
Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study. Biomedicines. 2023; 11(10):2689.
https://doi.org/10.3390/biomedicines11102689
Chicago/Turabian Style
Nakhleh, Afif, Areen Othman, Amin Masri, Moshe Zloczower, Sagit Zolotov, and Naim Shehadeh.
2023. "Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study" Biomedicines 11, no. 10: 2689.
https://doi.org/10.3390/biomedicines11102689
APA Style
Nakhleh, A., Othman, A., Masri, A., Zloczower, M., Zolotov, S., & Shehadeh, N.
(2023). Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study. Biomedicines, 11(10), 2689.
https://doi.org/10.3390/biomedicines11102689
